Research Correspondence

Strategy for surgical correction and mitigation of outflow graft twist with a centrifugal-flow left ventricular assist system

Disclaimer

The customized titanium cuff to secure the outflow graft used in these patients is not currently commercially available and has no United States Food and Drug Administration or Conformité Européene mark approval. It was designed and developed in Berlin to address the problem of free rotation of the outflow graft swivel joint. Both patients were at extreme risk for a pump exchange, and the cuff was implanted under the conditions of compassionate use to minimize harm to the patient. The device

Disclosure statement

E.V.P. reports proctoring for Abbott and Medtronic. I.N. reports consulting, institutional grants, and advisory board for Abbott and is on the advisory board for Carmat SA. F.K. reports consulting for Medtronic. V.F. reports institutional grants from Abbott, Medtronic, and Edwards and is on the advisory boards for Medtronic, BerlinHeart, and Novartis. M.R.M. reports consulting for Abbott, Medtronic, Janssen, Mesoblast, Portola, NupulseCV, and Bayer.

M.R.M. notes that this paper does not